On December 5, 2017, the FDA released a safety advisory notifying doctors and patients of potential health hazards associated with Limbrel capsules. Limbrel was approved as a “medical food” that is intended to help manage the inflammation associated with osteoarthritis. It is available by prescripti
So-called “popcorn lung” is a serious lung disease that causes inflammation and scarring in the airways and eventually leads to permanent lung damage. The disease was so-named because back in the 1990s, an abnormally large number of microwave popcorn factory workers were diagnosed with “bronchioliti
If you’ve filed an Onglyza lawsuit, or if you’re thinking about it, mark January 25, 2018 on your calendar. That is the day that the U.S. Judicial Panel on Multidistrict Litigation will be hearing arguments about whether to consolidate all federally-filed cases before one court…
More than 20,500 Xarelto lawsuits are pending in consolidated litigation in the U.S. District Court for the Eastern District of Louisiana, and another 1,400 are pending in a mass tort in Philadelphia. Plaintiffs claim that after taking the blood-thinning medication, they developed serious side effec
In June 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally-filed testosterone replacement lawsuits into one court in the Northern District of Illinois. District Court Judge Matthew Kennelly is overseeing the pre-trial proceedings. The lawsuits before Judge Ke
Back in July 2009, the FDA approved the new drug Onglyza (saxagliptin) for the treatment of type 2 diabetes. In 2014, however, they issued a drug safety communication stating that they had requested additional clinical trial data from the manufacturers, “to investigate a possible association…
In a new study published by the British Medical Journal (BMJ), researchers reported that so-called “new-generation” blood thinners like Xarelto and Eliquis were no safer when it came to the risk of excessive bleeding than warfarin, the leading blood thinner for decades. A second study…
On October 25, 2017, a Georgia man filed a new Onglyza lawsuit against manufacturers Bristol-Myers Squibb and AstraZeneca Pharmaceuticals, in the U.S. District Court for the Middle District of Georgia. He claims that after taking Onglyza, which is a type 2 diabetes drug, he suffered…
In August 2017, the third Xarelto bellwether trial concluded in the U.S. District Court in Jackson, Mississippi. The jury sided with the drug manufacturers, Bayer and Johnson & Johnson. This was the third win for the defense in the consolidated federal proceedings. The plaintiff in…
When all federally-filed testosterone replacement lawsuits were consolidated in the Northern District of Illinois in 2014, District Judge Matthew Kennelly determined that AndroGel, would be the subject of the first several bellwether trials since it the most prescribed of the testosterone replacemen
Individuals who have irritable bowel syndrome (IBS) typically suffer from symptoms like abdominal pain, cramping, bloating, and diarrhea or constipation. Viberzi (eluxadoline), a prescription drug manufactured by Allergan, was approved in 2015 to treat IBS and help people manage their symptoms. Rece
On August 17, 2017, plaintiffs filed a new Zostavax lawsuit against manufacturer Merck & Co., Inc. Zostavax is a shingles vaccine that is meant to help reduce the risk of shingles in individuals 60 and over. The plaintiffs claim that after receiving Zostavax injections, that…